Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | SPTLC1 | O15269 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | SYK | P43405 | 2/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.35 |
| ▸ | TMIGD3 | P0DMS9 | 2/20 | 0.35 |
| ▸ | ADH5 | P11766 | 1/20 | 0.35 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.35 |
| ▸ | KDM5A | P29375 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23029791 | 0.85 | L3MBTL1 (0.54) | L3MBTL1SPTLC1SLC22A12SYKTNKS | |
| SCHEMBL23029808 | 0.83 | L3MBTL1 (0.51) | L3MBTL1SPTLC1SLC22A12SYKTNKS | |
| SCHEMBL25149587 | 0.83 | L3MBTL1 (0.51) | L3MBTL1RXFP1SYKALOX15JMJD6 | |
| SCHEMBL23029794 | 0.83 | L3MBTL1 (0.51) | L3MBTL1SYKHDAC6ADORA3TMIGD3 | |
| SCHEMBL29413476 | 0.80 | MAOB (0.40) | L3MBTL1SPTLC1SLC22A12XDHADORA3 | |
| SCHEMBL25149736 | 0.80 | L3MBTL1 (0.44) | L3MBTL1SPTLC1SLC22A12XDHSYK | |
| SCHEMBL12678003 | 0.78 | L3MBTL1 (0.47) | L3MBTL1SPTLC1SLC22A12SYKHDAC6 | |
| SCHEMBL454081 | 0.78 | SPTLC1 (0.53) | L3MBTL1SPTLC1SLC22A12XDHTNKS | |
| SCHEMBL16739621 | 0.78 | ADH5 (0.40) | L3MBTL1SPTLC1SLC22A12XDHSYK | |
| SCHEMBL2260742 | 0.74 | L3MBTL1 (0.67) | L3MBTL1TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118043321-A | Imidazo [1,2-a ] pyridine derivatives | 先正达农作物保护股份公司 | 2024-05-14 | — | — | CN | disclosed |
| US-6858613-B2 | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease | PFIZER INC. (US) | 2005-02-22 | — | — | US | disclosed |
| US-20030236264-A1 | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease | PHARMACIA & UPJOHN COMPANY | 2003-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236264-A1 | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease | NAT1, CYP11B1, COASY | L3MBTL1 3266/4885RXFP1 2951/4885SPTLC1 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.